The Patent Finder

Methods of Treating Erythropoietic Protoporphyria, X-Linked Protoporphyria, or Congenital Erythropoietic Porphyria with Glycine Transport Inhibitors

Disc Medicine, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 62/958,892, filed Jan 9, 2020. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 12,721,847Methods of Treating Erythropoietic Protoporphyria, X-Linked Protoporphyria, or Congenital Erythropoietic Porphyria with Glycine Transport Inhibitors
In force
 · High confidence
UsedRemaining
Disc Medicine, Inc.In forceHigh confidence
US 11,813,257Methods of Treating Erythropoietic Protoporphyria, X-Linked Protoporphyria, or Congenital Erythropoietic Porphyria with Glycine Transport Inhibitors
In force
 · High confidence
Disc Medicine, Inc.In forceHigh confidence
Application 18/941,469Methods of Treating Erythropoietic Protoporphyria, X-Linked Protoporphyria, or Congenital Erythropoietic Porphyria with Glycine Transport Inhibitors
Abandoned
Abandoned Oct 21, 2026
Disc Medicine, Inc.AbandonedAbandoned Oct 21, 2026
Application 18/280,774Compositions and Methods for Treating Anemia Associated with a Ribosomal Disorder
Pending
Not granted
Disc Medicine, Inc.PendingNot granted
Application 18/280,837Compositions and Methods for Treating Polycythemia
Pending
Not granted
Disc Medicine, Inc.PendingNot granted
Application 18/290,403Methods of Treating Erythropoietic Protoporphyria, X-Linked Protoporphyria, or Congenital Erythropoietic Porphyria with Glycine Transport Inhibitors
Pending
Not granted
Disc Medicine, Inc.PendingNot granted
Application 18/562,510Methods of Treating Erythropoietic Protoporphyria, X-Linked Protoporphyria, or Congenital Erythropoietic Porphyria with a Solid Form of Bitopertin
Pending
Not granted
Disc Medicine, Inc.PendingNot granted
Application 18/866,586Compositions and Methods for Treating Hepatic Porphyrias with Glycine Transport Inhibitors
Pending
Not granted
Disc Medicine, Inc.PendingNot granted
Application 18/923,904Compositions and Methods for Treating Polycythemia
Pending
Not granted
Disc Medicine, Inc.PendingNot granted
Application 19/077,940Methods of Treating Erythropoietic Protoporphyria, X-Linked Protoporphyria, or Congenital Erythropoietic Porphyria with Glycine Transport Inhibitors
Pending
Not granted
Disc Medicine, Inc.PendingNot granted
4 more records in this group · Pro
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14.
Upgrade to Pro
2 of these are in force and held by Disc Medicine, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited